Event coordinated by the Hepatitis B Foundation

International HBV Meeting Program

September 26-30, 2021

Session Topics

  • Preclinical targets and therapies for chronic hepatitis B
  • New technologies for liver research
  • Application of new technologies and advances in models for the study of HBV
  • HBV replication, gene expression and egress
  • HBV integration, genotypes and HCC
  • Viral entry, cccDNA biogenesis and homeostasis
  • Innate immunity to HBV infection
  • Adaptive immunity to HBV infection
  • Co-infection and pathogenesis
Please note: Session topics are subject to change until the program is finalized.

Click on the button below to download a copy of the International HBV Meeting Program. *Program is subject to change. All times are EDT. 
 
HBV Mtg Program Button
Sunday, September 26, 2021
5:00 pm to 6:20 pm

Welcome Remarks and Distinguished Award in Hepatitis B Research Presentations

6:20 pm to 7:30 pm

Welcome Reception 

Monday, September 27, 2021
8:00 am to 8:30 am

Coffee 

8:30 am to 10:30 am

Session I: Preclinical Targets & Therapies for Chronic Hepatitis B 

Session Chairs: 
Stephan Urban (Germany) and Fabien Zoulim (France) 

10:30 am to 11:00 am

HBF/ICE-HBV Updates with Tim Block and Fabien Zoulim

11:00 am to 12:30 pm

Poster Session I - Viral Replication and cccDNA 

12:30 pm to 1:30 pm

Lunch 

1:30 pm to 3:30 pm

Symposium: New Technologies for Liver Research 

Session Chairs:
Adam Gehring (Canada) and Ourania Andrisani (USA)

3:30 pm to 4:00 pm Coffee 
4:00 pm to 6:00 pm

Session II: Application of New Technologies and Advances in Models for the Study of HBV

Session Chairs: 
Helen Strick-Marchand (France) and Alex Ploss (USA)

6:00 pm to 7:30 pm 

Happy Hour and Poster Session 

Tuesday, September 28, 2021  
8:30 an to 10:30 am

Session III: HBV Replication, Gene Expression and Egress 

Session Chairs:
Michael Bouchard (USA) and Christine Neuvet (France)

10:30 am to 11:00 am Coffee 
11:00 am to 11:45 am

Keynote Presentation I: Xin Wei Wang, NIH

Session Chair:
Ourania Andrisani (USA)

11:45 to 1:00 pm Poster Session II: HCC, Integration, and Trafficking 
1:00 pm to 2:00 pm  Lunch 
2:00 pm to 4:00 pm

Session IV: Pathogenesis and HCC

Session Chairs:
Thomas Tu (Australia) and Massimo Levrero (France)

4:00 pm to 4:30 pm Coffee 
4:30 pm to 6:00 pm

Session V: Viral Entry, cccDNA Biogenesis and Homeostasis 

Session Chairs:
Lena Allweiss (Germany) and Haitao Guo (USA)

6:30 pm to 8:00 pm Happy Hour and Poster Session II
Wednesday, September 29, 2021  
8:00 am to 10:30 am

Session VI: Innate Immunity to HBV Infection

Session Chairs:
Ulrike Protzer (Germany) and Andre Boonstra (Netherlands)  

10:30 am to 11:00 am Coffee 
11:00 am to 11:45 am

Keynote Presentation II: Matteo Iannacone 

Session Chair:
Adam Gehring (Canada) 

11:45 am to 1:00 pm Poster Session III: Preclinical Targets 
1:00 pm to 2:00 pm Lunch 
2:00 pm to 4:00 pm

Session VII: Adaptive Immunity to HBV Infection 

Session Chairs:
Robert Thimme (Germany) and Laura Pallet (UK)

4:00 pm to 4:30 pm Coffee 
4:30 pm to 6:00 pm

Session VIII: Co-Infection (SARS-CoV-2/HDV/HIV) 

Session Chairs:
David Durantel (France) and Marc Lutgehetmann (Germany) 

6:00 pm to 6:20 pm Closing Remarks 
Thursday, September 30, 2021  
7:00 am to 9:00 am Hepatitis B Foundation and ICE-HBV Community Forum 
9:15 am - 1:00 pm ICE-HBV Cure Symposium